21 September 2023 – ACG, a leading supplier of fully integrated manufacturing solutions to the global pharmaceutical and nutraceutical industries, is pleased to announce the appointment of Borja Guerra as the vice president for international sales. In his new role, Borja Guerra will be responsible for leading sales and business development in all international markets...
Mumbai, India - 27 June 2023 - ACG announces full shareholding ownership of Technical Aluminium Foil Company (TAFC). This strategic move further solidifies ACG's growth trajectory across the Middle Eastern and African markets.
ACG, a leading supplier of fully integrated manufacturing solutions to the global pharmaceutical and nutraceutical industries, is pleased to announce the appointment of Rafael Costa as Vice President for the Americas region.
ACG: (The global pharmaceutical solutions company on a mission to help manufacturers keep their supply chains moving)
Mumbai, 12 September, 2022 - The current crisis in Europe has led to increasing energy insecurity and shortages of raw materials, which are creating severe pharmaceutical manufacturing supply line disruptions. In some cases, supplier lead times have doubled, prices are no longer certain, and orders are subject to cancellations or delays. ACG, the worldís largest...
Mumbai 26 April, 2022: ACG, a leading supplier of fully integrated manufacturing solutions to the global pharmaceutical and nutraceutical industry, is pleased to announce the appointment of Mr. Udit K Singh as the new chief executive officer (CEO) of its Inspection Division.
Mumbai 12th January, 2022 - New solution improves machine efficiency, prevents breakdowns, lowers costs and reduces risks whilst providing anytime, anywhere remote monitoring. ACG, the worldís leading integrated solutions provider for pharmaceutical companies, has introduced the Smart Connected Product - a new, innovative, IIoT solution, that connects production machines at any facility and visualises relevant...
3 November 2020 The investment is aimed at augmenting R&D and IP in drug development. The funds infusion will enable IQGEN-X to fast-track research on existing ANDAs and also setup a cGMP pilot facility in addition to the already existing R&D facility.
D Bhabrekar Nagar Road Mumbai, Maharashtra 400067, IN
+91 022 7186 2362 / +91 022 7186 2363